Immix Biopharma, Inc. (IMMX)
9.79
-0.30
(-2.97%)
USD |
NASDAQ |
Apr 21, 14:29
Immix Biopharma Market Cap : 518.52M for April 21, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.727B |
| Agenus, Inc. | 153.21M |
| Alnylam Pharmaceuticals, Inc. | 40.38B |
| Savara, Inc. | 1.095B |
| Arrowhead Pharmaceuticals, Inc. | 9.932B |
Market Cap Related Metrics
| PEG Ratio | -0.9109 |
| Price to Book Value | 5.528 |
| Price | 9.79 |
| Earnings Yield | -9.10% |
| PEGY Ratio | -0.9109 |